Kailera
Clinical trials sponsored by Kailera, explained in plain language.
-
New weekly shot aims to tackle obesity and diabetes together
Disease control Recruiting nowThis study tests a new medicine called KAI-9531, given as a weekly shot, to see if it helps people with obesity or overweight and type 2 diabetes lose weight and lower blood sugar. About 1,700 adults will receive either the drug or a placebo for 76 weeks. The goal is to find a be…
Phase: PHASE3 • Sponsor: Kailera • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC
-
New obesity drug KAI-9531 takes on semaglutide in major trial
Disease control Recruiting nowThis study tests a new weekly injection called KAI-9531 to help people with obesity lose weight. About 1,200 adults with a BMI of 35 or higher who do not have diabetes will receive either KAI-9531, semaglutide (a current weight-loss drug), or a placebo. The main goal is to see ho…
Phase: PHASE3 • Sponsor: Kailera • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC